The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-153-4435, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Amneal Pharmaceuticals of New York, Llc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 5 commercial cross-references from 3 manufacturers, enabling identification through both NSN and commercial part number lookups. 2 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-153-4435 |
| Primary Part Number | NDC69238-1839-01 |
| Item Name | Levothyroxine Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Amneal Pharmaceuticals of New York, Llc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 100.000 TABLETS |
| Active Medicament Medicinal Strength | 0.175 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC69238-1839-01 PRIMARY | Amneal Pharmaceuticals of New York, Llc (USA) |
| LEVOTHROID | Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc (USA) |
| LEVOTHROID TABLETS | Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc (USA) |
| NDC60793-0859-01 | Pfizer Inc (USA) |
| NDC60846-0810-01 | Amneal Pharmaceuticals of New York, Llc (USA) |
NSN 6505-01-153-4435 is a Levothyroxine Sodium Tablets, manufactured by Amneal Pharmaceuticals of New York, Llc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-153-4435 has 5 cross-referenced part numbers: NDC69238-1839-01 (Amneal Pharmaceuticals of New York, Llc), LEVOTHROID (Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc), LEVOTHROID TABLETS (Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc), NDC60793-0859-01 (Pfizer Inc), NDC60846-0810-01 (Amneal Pharmaceuticals of New York, Llc).
There are 2 known substitutes for 6505-01-153-4435: 6505-00-990-2021, 6505-01-094-1636. Verify interchangeability with system specifications before substitution.
Key specifications for NDC69238-1839-01: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 100.000 TABLETS; Active Medicament Medicinal Strength: 0.175 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT; Primary Container Type: BOTTLE. 6 total characteristics are documented in the Federal Logistics Information System.